<DOC>
	<DOCNO>NCT01181934</DOCNO>
	<brief_summary>This study young elderly healthy subject investigate effect nicotine arousal , cognitive task social cognition acute dose administration .</brief_summary>
	<brief_title>The Effect Nicotine Arousal , Cognition Social Cognition Young Elderly Healthy Subjects .</brief_title>
	<detailed_description>This double-blind ( neither physician subject know name assigned drug ) , placebo-controlled , randomize ( study drug assign chance ) , three-way-crossover trial ( participant may receive different intervention sequentially trial ) young elderly healthy volunteer . The three-way-crossover treatment phase consist three blind treatment period separate wash period ( period allow entire administer drug eliminate body ) 2 7 day . The study duration volunteer approximately 8 week . Each volunteer enrol randomized receive Treatment A ( 1mg nicotine per dose ) , Treatment B ( 2mg nicotine per dose ) Treatment C ( placebo ) one treatment period . The study drug ( nicotine placebo ) administer three time daily Day 1 treatment phase mouth spray , separate 2 3 hour ( i.e . 0h ; 2 3h ; 4 6h post first dose ) . Three different block cognitive assessment follow , one drug administration . Safety evaluation include adverse event monitoring , vital sign clinical laboratory test . Each volunteer participate receive 3 identical study drug administration per dose day ( 2 3 hour ) , result overall dose 3 mg nicotine ( Treatment A ) , 6 mg nicotine ( Treatment B ) 0 mg nicotine ( Treatment C ) per dose day . By end study , 3-way crossover , volunteer receive 9 mg nicotine via mouth spray .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Man woman 18 30 year age inclusive ( Cohort 1 ) Man woman 60 75 year age , inclusive ( Cohort 2 ) Body mass index ( BMI ) 18 35 kg/m2 , inclusive ( BMI = eight/height2 ) Women must : postmenopausal ( least 12 month ) , surgically sterile ( hysterectomy bilateral oophorectomy , tubal ligation , otherwise incapable pregnancy ) , abstinent ( discretion investigator/per local regulation ) , sexually active , practice highly effective method birth control must agree continue use method contraception throughout study Women childbearing potential must negative serum pregnancy test screen negative urine pregnancy test admission ( study period ) Men must agree use condom sexual intercourse donate sperm study 3 month receive last dose study drug . In addition , female partner also use appropriate method birth control least duration Female volunteer pregnant breastfeed Clinically significant abnormal value clinical chemistry , hematology urinalysis screening . It expect laboratory value generally within normal range laboratory , though minor deviation , consider clinical significance investigator , acceptable . Values alanine aminotransferase ( ALT ) /aspartate aminotransferase ( AST ) &lt; 2 fold Upper Limit Normal allow Clinically significant abnormal physical examination , vital sign 12lead ECG screen History epilepsy fit unexplained blackout Current dangerous aggressive behavior Clinically significant history drug and/or food allergy Recent history ( within previous 6 month ) alcohol drug abuse Significant history current significant medical illness include ( limited ) cardiac arrhythmia cardiac disease , hematological disease , bronchospastic respiratory disease , dyspnea , diabetes mellitus , renal hepatic insufficiency , thyroid disease , infection , illness investigator considers clinically significant exclude subject ( Subjects wellcontrolled hypertension allow participate ) Significant history current psychiatric neurological illness Smoking cigarette ( equivalent ) use nicotine base product , within 3 month prior study drug administration . Current use medication smoke cessation nicotine replacement therapy , bupropion varenicline Positive urine screen drug abuse screen admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>symptomatic treatment</keyword>
	<keyword>cognition</keyword>
	<keyword>cognitive deficit</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>